Christopher Raub - Dec 14, 2023 Form 4 Insider Report for Jackson Financial Inc. (JXN)

Role
EVP and Chief Risk Officer
Signature
/s/ Kristan L. Richardson, as Attorney-in-Fact
Stock symbol
JXN
Transactions as of
Dec 14, 2023
Transactions value $
$0
Form type
4
Date filed
12/18/2023, 04:37 PM
Previous filing
Dec 1, 2023
Next filing
Feb 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JXN Common Stock Award $0 +59 +0.34% $0.00 17.3K Dec 14, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JXN Restricted Share Units Award $0 +53.6 +0.29% $0.00 18.3K Dec 14, 2023 Common Stock 53.6 Direct F2, F3
transaction JXN Restricted Share Units Award $0 +73.7 +0.4% $0.00 18.4K Dec 14, 2023 Common Stock 73.7 Direct F2, F4
transaction JXN Restricted Share Units Award $0 +95.5 +0.52% $0.00 18.5K Dec 14, 2023 Common Stock 95.5 Direct F2, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired dividend equivalents in the form of Restricted Share Units ("RSUs"), which are subject to the same terms and conditions as the underlying equity granted to the recipient as the September 2023 Mid-Cycle Grant. These RSUs vest over three years, where the first third vests on the one-year anniversary of the grant date, September 10, 2024, the next third vests on the two-year anniversary of the grant date, September 10, 2025, and the remaining third vests on the three-year anniversary of the the grant date, September 10, 2026. Upon vesting, full shares will be distributed and the fractional shares will be applied to the shares withheld to cover tax obligations.
F2 Each restricted stock unit represents a contingent right to receive one share of JFI common stock.
F3 Acquired dividend equivalents in the form of Restricted Share Units ("RSUs"), which are subject to the same terms and conditions as the underlying equity granted to the recipient as the October 2021 Annual Grant. The RSUs vest in three equal annual installments with distributions settled in cash. The first third vested on October 4, 2022, the next third vested on October 4, 2023, and the remaining third vests on April 4, 2024.
F4 Acquired dividend equivalents in the form of Restricted Share Units ("RSUs"), which are subject to the same terms and conditions as the underlying equity granted to the recipient as the March 2022 Annual Grant. The RSUs vest in three equal annual installments with distributions settled in cash. The first third vested on March 10, 2023, the next third vests on March 10, 2024, and the remaining third on March 10, 2025.
F5 Acquired dividend equivalents in the form of Restricted Share Units ("RSUs"), which are subject to the same terms and conditions as the underlying equity granted to the recipient as the March 2023 Annual Grant. The RSUs vest in three equal annual installments with distributions settled in cash. The first third vests on March 10, 2024, the second third on March 10, 2025, and the remaining third on March 10, 2026.
F6 The total reflects adjustments to correct inadvertent errors in the number of shares awarded in the March 10, 2023, equity grant, and subsequent accruals of dividend equivalent units in March, June, and September, the number of RSUs that vested on an accelerated basis on November 29, 2023, and the number of shares withheld on that date.

Remarks:

Power of Attorney on file.